Magi-Galluzzi C - Search Results

1

Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.

Nguyen JK, Magi-Galluzzi C. Nguyen JK, et al. Adv Anat Pathol. 2018 Sep;25(5):293-303. doi: 10.1097/PAP.0000000000000192. Adv Anat Pathol. 2018. PMID: 29727322 Review.

2

Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.

Aydin H, Zhang J, Samaratunga H, Tan N, Magi-Galluzzi C, Klein E, Jones JS, Zhou M. Aydin H, et al. BJU Int. 2010 Feb;105(4):476-80. doi: 10.1111/j.1464-410X.2009.08812.x. Epub 2009 Aug 25. BJU Int. 2010. PMID: 19709071

3

Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.

Falzarano SM, Zhou M, Hernandez AV, Moussa AS, Jones JS, Magi-Galluzzi C. Falzarano SM, et al. Urology. 2010 Sep;76(3):682-7. doi: 10.1016/j.urology.2009.11.067. Epub 2010 Mar 5. Urology. 2010. PMID: 20206973

4

Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.

Zhou M, Magi-Galluzzi C. Zhou M, et al. Pathology. 2010 Jun;42(4):334-8. doi: 10.3109/00313021003767280. Pathology. 2010. PMID: 20438405

5

Prostate cancer staging and grading at radical prostatectomy over time.

Falzarano SM, Magi-Galluzzi C. Falzarano SM, et al. Adv Anat Pathol. 2011 Mar;18(2):159-64. doi: 10.1097/PAP.0b013e31820cb506. Adv Anat Pathol. 2011. PMID: 21326013 Review.

6

Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy.

Sinnott M, Falzarano SM, Hernandez AV, Jones JS, Klein EA, Zhou M, Magi-Galluzzi C. Sinnott M, et al. Prostate. 2012 Aug 1;72(11):1179-86. doi: 10.1002/pros.22467. Epub 2011 Dec 7. Prostate. 2012. PMID: 22161896

7

Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens.

Przybycin CG, Magi-Galluzzi C, McKenney JK. Przybycin CG, et al. Adv Anat Pathol. 2013 Jul;20(4):245-63. doi: 10.1097/PAP.0b013e318299b7c6. Adv Anat Pathol. 2013. PMID: 23752087 Review.

8

Epithelial-to-mesenchymal transition in renal neoplasms.

He H, Magi-Galluzzi C. He H, et al. Adv Anat Pathol. 2014 May;21(3):174-80. doi: 10.1097/PAP.0000000000000018. Adv Anat Pathol. 2014. PMID: 24713987 Review.

9

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. Klein EA, et al. Eur Urol. 2014 Sep;66(3):550-60. doi: 10.1016/j.eururo.2014.05.004. Epub 2014 May 16. Eur Urol. 2014. PMID: 24836057 Free article.

10

Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?

Chen DJ, Falzarano SM, McKenney JK, Przybycin CG, Reynolds JP, Roma A, Jones JS, Stephenson A, Klein E, Magi-Galluzzi C. Chen DJ, et al. BJU Int. 2015 Aug;116(2):220-9. doi: 10.1111/bju.12880. Epub 2014 Dec 15. BJU Int. 2015. PMID: 25060664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page